Clark A M, Baker J K, McChesney J D
J Pharm Sci. 1984 Apr;73(4):502-6. doi: 10.1002/jps.2600730418.
The metabolism of the 8-aminoquinoline antimalarial drug, primaquine (I) was studied using rats. The drug was administered intravenously, intraperitoneally, and orally, and blood samples were collected at various time intervals. Primaquine was metabolized by oxidative deamination to give 8-(3-carboxy-l- methylpropylamino )-6- methoxyquinoline (III). The plasma levels of both primaquine and its metabolite were determined by HPLC. The tissue distributions of radioactive primaquine after intravenous, intraperitoneal, and oral administrations were also determined. Significant concentrations of radioactivity were found in the lungs, adrenal glands, and liver. In addition, a significant portion of the dose was found to be excreted in the feces within 24 h after administration of the drug by either of the three routes.
使用大鼠对8-氨基喹啉抗疟药伯氨喹(I)的代谢进行了研究。通过静脉内、腹腔内和口服方式给药该药物,并在不同时间间隔采集血样。伯氨喹通过氧化脱氨代谢生成8-(3-羧基-1-甲基丙基氨基)-6-甲氧基喹啉(III)。通过高效液相色谱法测定伯氨喹及其代谢物的血浆水平。还测定了静脉内、腹腔内和口服给药后放射性伯氨喹的组织分布。在肺、肾上腺和肝脏中发现了显著浓度的放射性。此外,在通过三种途径之一给药后的24小时内,发现很大一部分剂量经粪便排出。